Tech Company Financing Transactions
iBio Funding Round
Private investors participated in a $6.2 million capital raise for iBio. This venture round was announced on 4/29/2025.
Transaction Overview
Company Name
Announced On
4/29/2025
Transaction Type
Venture Equity
Amount
$6,200,000
Round
Undisclosed
Investors
Proceeds Purpose
The Company intends to use the net proceeds for working capital and other general corporate purposes.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
11750 Sorrento Valley Road 200
San Diego, CA 92121
USA
San Diego, CA 92121
USA
Phone
Website
Email Address
Overview
iBio, Inc. is a biotechnology company focused on developing next-generation biopharmaceuticals for cardiometabolic diseases, obesity, cancer, and other hard-to-treat conditions. Leveraging AI and advanced computational biology, iBio utilizes proprietary 3D modeling and drug discovery platforms to create a pipeline of breakthrough antibody treatments. Their mission is to transform drug discovery, accelerate development timelines, and unlock new possibilities in precision medicine.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Martin Brenner
Chief Financial Officer
Felipe Duran
Browse more venture capital transactions:
Prev: 4/29/2025: eeden venture capital transaction
Next: 4/29/2025: VSORA venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on all VC transactions involving tech companies. VC transactions reported here are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs